These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 20348141)

  • 1. Clinical and laboratory risk factors of thrombotic complications after pacemaker implantation: a prospective study.
    Korkeila P; Mustonen P; Koistinen J; Nyman K; Ylitalo A; Karjalainen P; Lund J; Airaksinen J
    Europace; 2010 Jun; 12(6):817-24. PubMed ID: 20348141
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Risk of venous thromboembolism recurrence: high negative predictive value of D-dimer performed after oral anticoagulation is stopped.
    Palareti G; Legnani C; Cosmi B; Guazzaloca G; Pancani C; Coccheri S
    Thromb Haemost; 2002 Jan; 87(1):7-12. PubMed ID: 11848459
    [TBL] [Abstract][Full Text] [Related]  

  • 3. D-dimer and prothrombin fragment 1 + 2 predict venous thromboembolism in patients with cancer: results from the Vienna Cancer and Thrombosis Study.
    Ay C; Vormittag R; Dunkler D; Simanek R; Chiriac AL; Drach J; Quehenberger P; Wagner O; Zielinski C; Pabinger I
    J Clin Oncol; 2009 Sep; 27(25):4124-9. PubMed ID: 19636003
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Predictive value of D-dimer test for recurrent venous thromboembolism after anticoagulation withdrawal in subjects with a previous idiopathic event and in carriers of congenital thrombophilia.
    Palareti G; Legnani C; Cosmi B; Valdré L; Lunghi B; Bernardi F; Coccheri S
    Circulation; 2003 Jul; 108(3):313-8. PubMed ID: 12847064
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of selected prothrombotic and proinflammatory factors on the incidence of venous thrombosis after pacemaker implantation.
    Lelakowski J; Domagała TB; Rydlewska A; Januszek R; Kotula Horowitz K; Majewski J; Ząbek A; Małecka B; Musiał J
    Kardiol Pol; 2012; 70(3):260-7. PubMed ID: 22430407
    [TBL] [Abstract][Full Text] [Related]  

  • 6. 28 day post-operative persisted hypercoagulability after surgery for benign diseases: a prospective cohort study.
    Ulrych J; Kvasnicka T; Fryba V; Komarc M; Malikova I; Burget F; Brzezkova R; Kvasnicka J; Krska Z; Kvasnicka J
    BMC Surg; 2016 Apr; 16():16. PubMed ID: 27048604
    [TBL] [Abstract][Full Text] [Related]  

  • 7. ADAMTS-13 and von Willebrand factor predict venous thromboembolism in patients with cancer.
    Pépin M; Kleinjan A; Hajage D; Büller HR; Di Nisio M; Kamphuisen PW; Salomon L; Veyradier A; Stepanian A; Mahé I
    J Thromb Haemost; 2016 Feb; 14(2):306-15. PubMed ID: 26589836
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Thrombotic variables and risk of idiopathic venous thromboembolism in women aged 45-64 years. Relationships to hormone replacement therapy.
    Lowe G; Woodward M; Vessey M; Rumley A; Gough P; Daly E
    Thromb Haemost; 2000 Apr; 83(4):530-5. PubMed ID: 10780311
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Progression of venous pathology after pacemaker and cardioverter-defibrillator implantation: A prospective serial venographic study.
    Korkeila P; Ylitalo A; Koistinen J; Airaksinen KE
    Ann Med; 2009; 41(3):216-23. PubMed ID: 18979290
    [TBL] [Abstract][Full Text] [Related]  

  • 10. D-Dimer and prothrombin fragment 1 + 2 in urine and plasma in patients with clinically suspected venous thromboembolism.
    Wexels F; Seljeflot I; Pripp AH; Dahl OE
    Blood Coagul Fibrinolysis; 2016 Jun; 27(4):396-400. PubMed ID: 26595215
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Association between selected risk factors and the incidence of venous obstruction after pacemaker implantation: demographic and clinical factors.
    Lelakowski J; Domagała TB; Cieśla-Dul M; Rydlewska A; Majewski J; Piekarz J; Kotula-Horowitz K; Sadowski J
    Kardiol Pol; 2011; 69(10):1033-40. PubMed ID: 22006604
    [TBL] [Abstract][Full Text] [Related]  

  • 12. D-dimer levels in combination with residual venous obstruction and the risk of recurrence after anticoagulation withdrawal for a first idiopathic deep vein thrombosis.
    Cosmi B; Legnani C; Cini M; Guazzaloca G; Palareti G
    Thromb Haemost; 2005 Nov; 94(5):969-74. PubMed ID: 16363238
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Coagulation and fibrinolysis activation after single-incision versus standard laparoscopic cholecystectomy: a single-center prospective case-controlled pilot study.
    Zezos P; Christoforidou A; Kouklakis G; Tsalikidis C; Dimakis C; Laftsidis P; Virgiliou A; Simopoulos C; Pitiakoudis M
    Surg Innov; 2014 Feb; 21(1):22-31. PubMed ID: 23575915
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Venous thromboembolism in carriers of the Factor V Leiden mutation and in patients without known thrombophilic risk factor; prediction of recurrence and APC-PCI complex concentration and/or soluble thrombomodulin antigen and activity.
    Strandberg K; Svensson PJ; Ohlin AK
    Thromb Res; 2007; 121(2):145-51. PubMed ID: 17499343
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Factor V Leiden (G1691A) and prothrombin gene G20210A mutations as potential risk factors for venous thromboembolism after total hip or total knee replacement surgery.
    Wåhlander K; Larson G; Lindahl TL; Andersson C; Frison L; Gustafsson D; Bylock A; Eriksson BI
    Thromb Haemost; 2002 Apr; 87(4):580-5. PubMed ID: 12008938
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Increased ADAMTS13 activity in patients with venous thromboembolism.
    Mazetto BM; Orsi FL; Barnabé A; De Paula EV; Flores-Nascimento MC; Annichino-Bizzacchi JM
    Thromb Res; 2012 Dec; 130(6):889-93. PubMed ID: 23031329
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Plasma levels of haemostatic factors in patients with pulmonary embolism on admission and seven months later.
    Sane M; Granér M; Laukkanen JA; Harjola VP; Mustonen P
    Int J Lab Hematol; 2018 Feb; 40(1):66-71. PubMed ID: 28868636
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Venous obstruction after permanent pacing.
    Kar AK; Ghosh S; Majumdar A; Mondal M; Dutta I
    Indian Heart J; 2000; 52(4):431-3. PubMed ID: 11084785
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Incidence and risk factors of early venous thrombosis associated with permanent pacemaker leads.
    van Rooden CJ; Molhoek SG; Rosendaal FR; Schalij MJ; Meinders AE; Huisman MV
    J Cardiovasc Electrophysiol; 2004 Nov; 15(11):1258-62. PubMed ID: 15574174
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clotting activation after oral anticoagulant therapy discontinuation: a risk factor for recurrent venous thromboembolism.
    Poli D; Antonucci E; Cecchi E; Betti I; Lapini I; Gazzini A; Abbate R; Gensini GF; Prisco D
    Blood Coagul Fibrinolysis; 2004 Apr; 15(3):221-5. PubMed ID: 15060417
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.